Timeliness of lung cancer diagnosis and treatment in a rapid outpatient diagnostic program with combined 18FDG-PET and contrast enhanced CT scanning

Lung Cancer

Volumn 75, Issue 3, 2012, Pages 336-341

  Brocken, Pepijn ^a   Kiers, Berni A B ^a   Looijen Salamon, Monika G ^a   Dekhuijzen, Richard P N ^a   Smits Van der Graaf, Chantal ^a   Peters Bax, Liesbeth ^a   De Geus Oei, Lioe Fee ^a   Van Der Heijden, Henricus F M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Delay; Diagnosis; Lung cancer; Quality of care; Rapid outpatient diagnostic program; Timeliness

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PALLIATIVE THERAPY; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; DELAYED DIAGNOSIS; FEMALE; FOLLOW UP; HEMOPTYSIS; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PATIENT REFERRAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TERTIARY HEALTH CARE; THERAPY DELAY;

AGED; AMBULATORY CARE; BRONCHOSCOPY; FEMALE; FLUORODEOXYGLUCOSE F18; HEALTH PLANNING GUIDELINES; HETEROCYCLIC COMPOUNDS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NETHERLANDS; ORGANOMETALLIC COMPOUNDS; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84856566814     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2011.08.017     Document Type: Article

References (52)

1. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics. CA Cancer J Clin 2010, 60:277-300.
2. Christensen E.D., Harvald T., Jendresen M., Aggestrup S., Petterson G. The impact of delayed diagnosis of lung cancer on the stage at the time of operation. Eur J Cardiothorac Surg 1997, 12:880-884.
3. O'Rourke N., Edwards R. Lung cancer treatment waiting times and tumour growth. Clin Oncol (R Coll Radiol) 2000, 12:141-144.
4. Annakkaya A.N., Arbak P., Balbay O., Birgin C., Erbas M., Bulut I. Effect of symptom-to-treatment interval on prognosis in lung cancer. Tumori 2007, 93:61-67.
5. Buccheri G., Ferrigno D. Lung cancer: clinical presentation and specialist referral time. Eur Respir J 2004, 24:898-904.
6. Kanashiki M., Satoh H., Ishikawa H., Yamashita Y.T., Ohtsuka M., Sekizawa K. Time from finding abnormality on mass-screening to final diagnosis of lung cancer. Oncol Rep 2003, 10:649-652.
7. British Thoracic Society BTS recommendations to respiratory physicians for organising the care of patients with lung cancer. Thorax 1998, 53:S1-S8.
8. Reifel J. Lung Cancer. Quality of care for oncologic conditions and HIV: a review of the literature and quality indicators 2000, RAND Corporation. S. Asch, E. Kerr, E. Hamilton, A. et (Eds.).
9. Alberts W.M., Bepler G., Hazelton T., Ruckdeschel J.C., Williams J.H. American College of Chest Physicians. Practice organization. Chest 2003, 123:332S-337S.
10. Dutch Association of Physicians for Pulmonary Disease and Tuberculosis Non-small cell lung cancer guideline: staging and treatment 2004, Van Zuiden Communications.
11. Olsson J.K., Schultz E.M., Gould M.K. Timeliness of care in patients with lung cancer: a systematic review. Thorax 2009, 64:749-775.
12. Brocken P., Prins J.B., Dekhuijzen P.N.R., Van der Heijden H.F.M. The faster the better?-a systematic review on distress in the diagnostic phase of suspected cancer, and the influence of rapid diagnostic pathways. Psycho-Oncology 2011, 20. 10.1002/pon.1929.
13. Benedict S., Williams R.D., Baron P.L. Recalled anxiety: from discovery to diagnosis of a benign breast mass. Oncol Nurs Forum 1994, 21:1723-1727.
14. Risberg T., Sorbye S.W., Norum J., Wist E.A. Diagnostic delay causes more psychological distress in female than in male cancer patients. Anticancer Res 1996, 16:995-999.
15. Dey P., Bundred N., Gibbs A., Hopwood P., Baildam A., Boggis C., et al. Costs and benefits of a one stop clinic compared with a dedicated breast clinic: randomised controlled trial. BMJ 2002, 324:507.
16. Ubhi S.S., Shaw P., Wright S., Stotter A., Clarke L., Windle R., et al. Anxiety in patients with symptomatic breast disease: effects of immediate versus delayed communication of results. Ann R Coll Surg Engl 1996, 78:466-469.
17. Harcourt D., Ambler N., Rumsey N., Cawthorn S.J. Evaluation of a one-stop breast lump clinic: a randomized controlled trial. The Breast 1998, 4:314-319.
18. Lewis N.R., Le Jeune I., Baldwin D.R. Under utilisation of the 2-week wait initiative for lung cancer by primary care and its effect on the urgent referral pathway. Br J Cancer 2005, 93(8):905-908.
19. Conron M., Phuah S., Steinfort D., Dabscheck E., Wright G., Hart D. Analysis of multidisciplinary lung cancer practice. Intern Med J 2007, 37:18-25.
20. Dransfield M.T., Lock B.J., Garver R.I. Improving the lung cancer resection rate in the US Department of Veterans Affairs Health System. Clin Lung Cancer 2006, 7:268-272.
21. Riedel R.F., Wang X., McCormack M., Toloza E., Montana G.S., Schreiber G., et al. Impact of a multidisciplinary thoracic oncology clinic on the timeliness of care. J Thorac Oncol 2006, 1:692-696.
22. Leary A., Corrigan P. Redesign of thoracic surgical services within a cancer network-using an oncology focus to inform change. Eur J Oncol Nurs 2005, 9:74-78.
23. Lo D.S., Zeldin R.A., Skrastins R., Fraser I.M., Newman H., Monavvari A., et al. Time to treat: a system redesign focusing on decreasing the time from suspicion of lung cancer to diagnosis. J Thorac Oncol 2007, 2:1001-1006.
24. Laroche C., Wells F., Coulden R., Stewart S., Goddard M., Lowry E., et al. Improving surgical resection rate in lung cancer. Thorax 1998, 53:445-449.
25. Murray P.V., O'Brien M.E., Sayer R., Knowles G., Miller A.C., Varney V., et al. The pathway study: results of a pilot feasibility study in patients suspected of having lung carcinoma investigated in a conventional chest clinic setting compared to a centralised two-stop pathway. Lung Cancer 2003, 42:283-290.
26. De Wever W., Stroobants S., Coolen J., Verschakelen J.A. Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration. Eur Respir J 2009, 33:201-212.
27. Subedi N., Scarsbrook A., Darby M., Korde K., Mc Shane P., Muers M.F. The clinical impact of integrated FDG PET-CT on management decisions in patients with lung cancer. Lung Cancer 2009, 64:301-307.
28. Mountain C.F. Revisions in the International System for Staging Lung Cancer. Chest 1997, 111:1710-1717.
29. 18F-FDG PET-CT for differentiation of pulmonary pathology in an approach of outpatient fast track assessment. J Thorac Oncol 2009, 4:1226-1230.
30. Smith S.M., Campbell N.C., MacLeod U., Lee A.J., Raja A., Wyke S., et al. Factors contributing to the time taken to consult with symptoms of lung cancer: a cross-sectional study. Thorax 2009, 64:523-531.
31. Corner J., Hopkinson J., Roffe L. Experience of health changes and reasons for delay in seeking care: a UK study of the months prior to the diagnosis of lung cancer. Soc Sci Med 2006, 62:1381-1391.
32. Koyi H., Hillerdal G., Branden E. Patient's and doctors' delays in the diagnosis of chest tumors. Lung Cancer 2002, 35:53-57.
33. Salomaa E.R., Sallinen S., Hiekkanen H., Liippo K. Delays in the diagnosis and treatment of lung cancer. Chest 2005, 128:2282-2288.
34. Yilmaz A., Damadoglu E., Salturk C., Okur E., Tuncer L.Y., Halezeroglu S., et al. Delays in the diagnosis and treatment of primary lung cancer: are longer delays associated with advanced pathological stage?. Ups J Med Sci 2008, 113:287-296.
35. Ozlu T., Bulbul Y., Oztuna F., Can G. Time course from first symptom to the treatment of lung cancer in the Eastern Black Sea Region of Turkey. Med Princ Pract 2004, 13:211-214.
36. Chandra S., Mohan A., Guleria R., Singh V., Yadav P. Delays during the diagnostic evaluation and treatment of lung cancer. Asian Pac J Cancer Prev 2009, 10:453-456.
37. Smith L.K., Pope C., Botha J. Patients' help-seeking experiences and delay in cancer presentation: a qualitative synthesis. Lancet 2005, 366:825-831.
38. Devbhandari M.P., Soon S.Y., Quennell P., Barber P., Krysiak P., Shah R., et al. UK waiting time targets in lung cancer treatment: are they achievable? Results of a prospective tracking study. J Cardiothorac Surg 2007, 2:5.
39. Neal R.D., Allgar V.L., Ali N., Leese B., Heywood P., Proctor G., et al. Stage, survival and delays in lung, colorectal, prostate and ovarian cancer: comparison between diagnostic routes. Br J Gen Pract 2007, 57:212-219.
40. Liberman M., Liberman D., Sampalis J.S., Mulder D.S. Delays to surgery in non-small-cell lung cancer. Can J Surg 2006, 49:31-36.
41. Kesson E., Bucknall C.E., McAlpine L.G., Milroy R., Hole D., Vernon D.R., et al. Lung cancer-management and outcome in Glasgow, 1991-92. Br J Cancer 1998, 78:1391-1395.
42. Yorio J.T., Xie Y., Yan J., Gerber D.E. Lung cancer diagnostic and treatment intervals in the United States: a health care disparity?. J Thorac Oncol 2009, 4:1322-1330.
43. Gould M.K., Ghaus S.J., Olsson J.K., Schultz E.S. Timeliness of care in veterans with non-small cell lung cancer. Chest 2008, 133:1167-1173.
44. Kashiwabara K., Koshi S., Itonaga K., Nakahara O., Tanaka M., Toyonaga M., et al. Outcome in patients with lung cancer found on lung cancer mass screening roentgenograms, but who did not subsequently consult a doctor. Lung Cancer 2003, 40:67-72.
45. Comber H., Cronin D.P., Deady S., Lorcain P.O., Riordan P. Delays in treatment in the cancer services: impact on cancer stage and survival. Ir Med J 2005, 98:238-239.
46. Myrdal G., Lambe M., Hillerdal G., Lamberg K., Agustsson T., Ståhle E. Effect of delays on prognosis in patients with non-small cell lung cancer. Thorax 2004, 59:45-49.
47. Kashiwabara K., Koshi S., Ota K., Tanaka M., Toyonaga M. Outcome in patients with lung cancer found retrospectively to have had evidence of disease on past lung cancer mass screening roentgenograms. Lung Cancer 2002, 35:237-241.
48. Aragoneses F.G., Moreno N., Leon P., Fontan E.G., Folgue E. Influence of delays on survival in the surgical treatment of bronchogenic carcinoma. Lung Cancer 2002, 36:59-63.
49. Bozcuk H., Martin C. Does treatment delay affect survival in non-small cell lung cancer? A retrospective analysis from a single UK centre. Lung Cancer 2001, 34:243-252.
50. Stoll L.M., Yung R.C., Clark D.P., Li Q.K. Cytology of endobronchial ultrasound-guided transbronchial needle aspiration versus conventional transbronchial needle aspiration. Cancer Cytopathol 2010, 118:278-286.
51. Chao T.Y., Chien M.T., Lie C.H., Chung Y.H., Wang J.L., Lin M.C. Endobronchial ultrasonography-guided transbronchial needle aspiration increases the diagnostic yield of peripheral pulmonary lesions: a randomized trial. Chest 2009, 136:229-236.
52. Liao M.N., Chen M.F., Chen S.C., Chen P.L. Uncertainty and anxiety during the diagnostic period for women with suspected breast cancer. Cancer Nurs 2008, 31:274-283.